Yang, P., Blumenschein, W., Bauché, D., Mauze, S., Kochel, C., Grein, J., . . . Laface, D. Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions. BMJ Publishing Group.
Chicago Style (17th ed.) CitationYang, Peng, et al. Antitumor Efficacy of Combined CTLA4/PD-1 Blockade Without Intestinal Inflammation Is Achieved by Elimination of FcγR Interactions. BMJ Publishing Group.
MLA (9th ed.) CitationYang, Peng, et al. Antitumor Efficacy of Combined CTLA4/PD-1 Blockade Without Intestinal Inflammation Is Achieved by Elimination of FcγR Interactions. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.